Guillermo Morel, MD
Geriatric Medicine · Sebastian, FLNPI 1992827091
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 129 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,572, 5.9 times the $266 reported in 2019. Among geriatric medicine clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 129 payments — averaging $37.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$702
- AstraZeneca$535
- Novo Nordisk$504
- Astellas Pharma US Inc$330
- Atricure, Inc.$327
- Abbott$257
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,69198%
- Education$1082%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 8 | $702 |
| AstraZeneca | 7 | $535 |
| Novo Nordisk | 19 | $504 |
| Astellas Pharma US Inc | 9 | $330 |
| Atricure, Inc. | 2 | $327 |
| Abbott | 4 | $257 |
| Eisai Inc. | 6 | $255 |
| Edwards Lifesciences | 2 | $209 |
| Lilly USA, LLC | 12 | $205 |
| AbbVie(2 entities) | 4 | $198 |
| Corcept Therapeutics | 4 | $162 |
| Amgen | 7 | $136 |
| Novartis | 7 | $129 |
| Pfizer | 5 | $120 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $78 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $74 |
| GSK | 3 | $68 |
| Exact Sciences | 3 | $64 |
| Bayer | 2 | $59 |
| Mylan Specialty L.p. | 3 | $58 |
| Insmed, Inc. | 2 | $49 |
| Sanofi-aventis U.S. LLC | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $27 |
| E.r. Squibb & Sons, L.L.C. | 2 | $26 |
| Sanofi Pasteur Inc. | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $22 |
| Boehringer Ingelheim | 1 | $20 |
| Medtronic | 1 | $18 |
| Seqirus USA Inc | 1 | $18 |
| Corium, LLC | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WATCHMAN Access System$469
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$327
- FARXIGA$228
- SAPIEN 3 Ultra RESILIA$140
- WATCHMAN FLX$136
- Veozah$125
- LOKELMA$125
- Leqembi$125
- Korlym$124
- VRAYLAR$123
- AIRSUPRA$122
- ABSOLUTE PRO$119
- Wegovy$115
How this compares
$4,799 in reported general payments places this provider in the 90th percentile of 305 geriatric medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 78 | $130,045 |
| EliquisApixaban | 80 | $92,311 |
| JardianceEmpagliflozin | 43 | $48,240 |
| RybelsusSemaglutide | 18 | $47,140 |
| LinzessLinaclotide | 33 | $39,458 |
| JanuviaSitagliptin Phosphate | 24 | $38,893 |
| MounjaroTirzepatide | 27 | $36,487 |
| JanumetSitagliptin Phos/Metformin Hcl | 30 | $27,771 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 24 | $22,456 |
| XareltoRivaroxaban | 21 | $20,841 |
| EntrestoSacubitril/Valsartan | 16 | $16,877 |
| MyrbetriqMirabegron | 25 | $14,574 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 11 | $11,359 |
| SymbicortBudesonide/Formoterol Fumarate | 25 | $7,376 |
| Tresiba Flextouch U-100Insulin Degludec | 12 | $6,721 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $504 | $177,18496 claims |
| PfizerEliquis | $120 | $92,31180 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat | $20 | $59,59954 claims |
| AbbVieLinzess, Synthroid | $198 | $42,22376 claims |
| Lilly USA, LLCMounjaro | $205 | $36,48727 claims |
| GSKTrelegy Ellipta | $68 | $22,45624 claims |
| Johnson & JohnsonXarelto | $13 | $20,84121 claims |
| NovartisEntresto | $129 | $16,87716 claims |
| Astellas Pharma US IncMyrbetriq | $330 | $14,57425 claims |
| AstraZenecaSymbicort | $535 | $7,37625 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 305 geriatric medicine providers in Florida.
Other geriatric medicine in Sebastian
- Eileen FerminSebastian$5K
- Malcolm FraserBrooksville$359K
- Andrew ScanameoTallahassee$172K
- Naushira PandyaDavie$145K
- Rosemary LairdViera$64K
- Jonathan AppelbaumMonticello$59K
- John PotomskiMelbourne$31K
- Valeria Baldivieso HurtadoWinter Park$28K
- Kae FerberNaples$18K
- Stuti DangMiami$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.